Repurposing a drug for abdominal cancer

4 agosto 2014

A repurposed drug originally used to treat ovarian cancer saw positive results for patients with advanced peritoneal cancers during a phase I clinical trial, researchers report. The drug, known under the brand name Nanotax, is a fine particle reformulation of paclitaxel, the standard treatment for ovarian cancer. It works by flipping the script on how paclitaxel is administered to patients and with how it’s formulated, potentially making it a more effective and better tolerated treatment for ovarian and other abdominal cancers.